AU2011295629B2 - Perfusion composition - Google Patents

Perfusion composition Download PDF

Info

Publication number
AU2011295629B2
AU2011295629B2 AU2011295629A AU2011295629A AU2011295629B2 AU 2011295629 B2 AU2011295629 B2 AU 2011295629B2 AU 2011295629 A AU2011295629 A AU 2011295629A AU 2011295629 A AU2011295629 A AU 2011295629A AU 2011295629 B2 AU2011295629 B2 AU 2011295629B2
Authority
AU
Australia
Prior art keywords
heart
perfusion
sodium
aqueous solution
donor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2011295629A
Other languages
English (en)
Other versions
AU2011295629A1 (en
Inventor
Marlin L. Alford
Robert Dowben
Franklin Lawrence Rosenfeldt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organ Transport Pty Ltd
Original Assignee
Organ Transp Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organ Transp Pty Ltd filed Critical Organ Transp Pty Ltd
Publication of AU2011295629A1 publication Critical patent/AU2011295629A1/en
Assigned to PERFUSION FLUID TECHNOLOGIES, INC. reassignment PERFUSION FLUID TECHNOLOGIES, INC. Request for Assignment Assignors: ORGAN PERFUSION PTY LIMITED
Application granted granted Critical
Publication of AU2011295629B2 publication Critical patent/AU2011295629B2/en
Assigned to Organ Transport Pty Ltd reassignment Organ Transport Pty Ltd Request for Assignment Assignors: PERFUSION FLUID TECHNOLOGIES, INC.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AU2011295629A 2010-09-01 2011-09-01 Perfusion composition Active AU2011295629B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US37920710P 2010-09-01 2010-09-01
US61/379,207 2010-09-01
US201161474722P 2011-04-12 2011-04-12
US61/474,722 2011-04-12
PCT/AU2011/001121 WO2012027787A1 (fr) 2010-09-01 2011-09-01 Composition de perfusion

Publications (2)

Publication Number Publication Date
AU2011295629A1 AU2011295629A1 (en) 2013-03-28
AU2011295629B2 true AU2011295629B2 (en) 2014-05-01

Family

ID=45772009

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011295629A Active AU2011295629B2 (en) 2010-09-01 2011-09-01 Perfusion composition

Country Status (6)

Country Link
US (1) US9060507B2 (fr)
EP (1) EP2611291B1 (fr)
JP (1) JP5705324B2 (fr)
AU (1) AU2011295629B2 (fr)
CA (1) CA2809514C (fr)
WO (1) WO2012027787A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE1330158A1 (sv) * 2013-12-30 2015-07-01 Vivoline Medical Ab Insats för en transportanordning för organ
SG10202011833TA (en) 2015-05-29 2021-01-28 Univ Pennsylvania Compositions and methods for degradation of misfolded proteins
US20180146660A1 (en) * 2015-06-05 2018-05-31 University Of Maryland, Baltimore Use of Recombinant Human Activated Protein C to Enhance Viability of Transplant Tissue
GB201511207D0 (en) * 2015-06-25 2015-08-12 Xvivo Perfusion Ab Isolated organ evaluation and treatment
US11260027B2 (en) 2015-07-29 2022-03-01 Musc Foundation For Research Development Donor organ pre-treatment formulation
DK3448149T3 (da) * 2017-01-17 2019-11-04 Xvivo Perfusion Ab Organkonserverings- og/eller perfusionsopløsninger
GB2587350B (en) * 2019-09-23 2021-12-15 Royal Papworth Hospital Nhs Found Trust Organ perfusion system and method
KR20220063263A (ko) * 2019-11-08 2022-05-17 가부시키가이샤 바이오베르데 줄기세포용 냉장 보존액
CN113181121A (zh) * 2021-04-29 2021-07-30 海南通用三洋药业有限公司 一种果糖二磷酸钠无菌粉针剂的制备方法
EP4338590A1 (fr) * 2021-05-11 2024-03-20 Bmg Incorporated Solution de stockage à froid et procédé de stockage pour cellules souches

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006118990A2 (fr) * 2005-04-29 2006-11-09 Transplan, Inc. Procede et dispositif destines a la perfusion d'organe

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3326177B2 (ja) * 1992-06-26 2002-09-17 鳥居薬品株式会社 臓器保存液
CA2207324A1 (fr) * 1994-12-12 1996-06-20 Richard M. Raymond Solutions pour la transplantation d'organes et technique de transplantation d'organes
US5965433A (en) 1996-05-29 1999-10-12 Trans D.A.T.A. Service, Inc. Portable perfusion/oxygenation module having mechanically linked dual pumps and mechanically actuated flow control for pulsatile cycling of oxygenated perfusate
US6100082A (en) 1997-09-23 2000-08-08 Hassanein; Waleed H. Perfusion apparatus and method including chemical compositions for maintaining an organ
EP1017274B1 (fr) * 1997-09-23 2003-11-12 Waleed H. Hassanein Compositions, procedes et dispositifs permettant de conserver un organe
CA2342944A1 (fr) * 1998-09-29 2000-04-06 Organ Recovery Systems, Inc. Dispositif et procede permettant de maintenir et/ou de restaurer la viabilite d'organes
US6977140B1 (en) 1998-09-29 2005-12-20 Organ Recovery Systems, Inc. Method for maintaining and/or restoring viability of organs
US6673594B1 (en) * 1998-09-29 2004-01-06 Organ Recovery Systems Apparatus and method for maintaining and/or restoring viability of organs
US6492103B1 (en) * 2000-01-31 2002-12-10 Organ Recovery Systems, Inc. System for organ and tissue preservation and hypothermic blood substitution
US6677150B2 (en) 2001-09-14 2004-01-13 Organ Transport Systems, Inc. Organ preservation apparatus and methods
DE10262084B4 (de) * 2002-05-17 2009-12-24 Dr. Franz Köhler Chemie GmbH Protektive Lösung zur Verhinderung von Ischämieschäden
US7897327B2 (en) 2003-06-02 2011-03-01 Organ Recovery Systems, Inc. Method and apparatus for pressure control for maintaining viability of organs
US8304181B2 (en) 2004-10-07 2012-11-06 Transmedics, Inc. Method for ex-vivo organ care and for using lactate as an indication of donor organ status
US8465970B2 (en) 2004-10-07 2013-06-18 Transmedics, Inc. Systems and methods for ex-vivo organ care
US8637230B2 (en) * 2004-11-12 2014-01-28 Organoflush B.V. Composition for cold preservation and perfusion of organs
CA2605508A1 (fr) * 2005-05-12 2006-11-23 Wisconsin Alumni Research Foundation Blocage de pin1 pour empecher le production de cytokines par les cellules immunitaires activees
US9078428B2 (en) * 2005-06-28 2015-07-14 Transmedics, Inc. Systems, methods, compositions and solutions for perfusing an organ
BRPI0908181A2 (pt) * 2008-02-15 2015-08-18 Harvard College Solução de cardioplegia para cirurgia cardíaca
SE534527C2 (sv) * 2009-09-24 2011-09-20 Vivoline Medical Ab Förfarande, anordning och vätska för behandling av ett hjärta efter uttagning
FR2953684B1 (fr) * 2009-12-11 2012-02-17 Univ Claude Bernard Lyon Procede de perfusion hypothermique d'organes et dispositif de perfusion hypothermique pour sa mise en oeuvre

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006118990A2 (fr) * 2005-04-29 2006-11-09 Transplan, Inc. Procede et dispositif destines a la perfusion d'organe

Also Published As

Publication number Publication date
EP2611291B1 (fr) 2020-03-25
WO2012027787A1 (fr) 2012-03-08
EP2611291A4 (fr) 2014-05-14
US20130203041A1 (en) 2013-08-08
JP2013536804A (ja) 2013-09-26
CA2809514A1 (fr) 2012-03-08
AU2011295629A1 (en) 2013-03-28
US9060507B2 (en) 2015-06-23
JP5705324B2 (ja) 2015-04-22
CA2809514C (fr) 2014-10-28
EP2611291A1 (fr) 2013-07-10

Similar Documents

Publication Publication Date Title
AU2011295629B2 (en) Perfusion composition
Hicks et al. Organ preservation
Ceresa et al. The case for normothermic machine perfusion in liver transplantation
US10300029B2 (en) Organ protection solutions and method of use
US11033021B2 (en) Composition and solution with controlled calcium ion level, and related method and use for reperfusion
US10327441B2 (en) Modulation of calcium ion homeostasis in harvested transplantable hearts
US20240090494A1 (en) Perfusion solution
White et al. Avoidance of profound hypothermia during initial reperfusion improves the functional recovery of hearts donated after circulatory death
Gunnes et al. Fundamentals of the past: cardioplegia: the first period revisited
Zhang et al. Continuous perfusion of donor hearts with oxygenated blood cardioplegia improves graft function
Okamoto et al. Successful sub-zero non-freezing preservation of rat lungs at− 2° C utilizing a new supercooling technology
US20110159474A1 (en) Solutions for perfusing and preserving organs and tissues
AU2015336862B2 (en) Novel composition and solution with controlled calcium ion level, and related method and use for reperfusion
Conte et al. Overview and future practice patterns in cardiac and pulmonary preservation
Scheule et al. A non-heart-beating donor model to evaluate functional and morphologic outcomes in resuscitated pig hearts
Toledo-Pereyra et al. Kidney preservation
KR100304594B1 (ko) 이식용 장기 및 혈액세포 보존제의 조성물
Takeuchi et al. Prolonged preservation of the blood-perfused canine heart with glycolysis-promoting solution
Li et al. Effect of pressure on myocardial function after 6-hour preservation with blood cardioplegia
Moeslund et al. High Oxygen is Likely to be Beneficial on Cardiac Contractility after Normothermic Regional Perfusion after Circulatory Death in a Porcine Model
Seville The design and build of a portable heart preservation device to improve the retrieval of organs for transplantation

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: PERFUSION FLUID TECHNOLOGIES, INC.

Free format text: FORMER APPLICANT(S): ORGAN PERFUSION PTY LIMITED

FGA Letters patent sealed or granted (standard patent)
PC Assignment registered

Owner name: ORGAN TRANSPORT PTY LTD

Free format text: FORMER OWNER(S): PERFUSION FLUID TECHNOLOGIES, INC.